A few examples of stratified therapies used in the clinical practice include the case of non-small cell lung cancer (NSCLC), in which either the epidermal growth factor receptor (EGFR) (4) or the anaplastic lymphoma kinase (ALK) pathways are deregulated (5). The gene discussed is ALK; the disease is non-small cell lung carcinoma.